F1000Research (May 2017)

Pancreatic neuroendocrine tumors: the basics, the gray zone, and the target [version 1; referees: 3 approved]

  • Dionysia Kelgiorgi,
  • Christos Dervenis

DOI
https://doi.org/10.12688/f1000research.10188.1
Journal volume & issue
Vol. 6

Abstract

Read online

Pancreatic neuroendocrine tumors (PanNETs) manifest with a range of symptoms and pose a therapeutic challenge. A team approach, in which many specialists come together, is necessary in the quest for the best patient-tailored treatment. Disciplines such as oncology, surgery, basic science, endocrinology, radiology, and nuclear medicine need to work side by side, equally contributing to patient care and to advancing our better understanding of this fascinating disease.

Keywords